Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
Top Cited Papers
Open Access
- 28 January 2009
- journal article
- review article
- Published by Wiley in European Journal of Heart Failure
- Vol. 11 (2), 119-129
- https://doi.org/10.1093/eurjhf/hfn043
Abstract
The increasing prevalence of heart failure poses enormous challenges for health care systems worldwide. Despite effective medical interventions that target neurohumoral activation, mortality and morbidity remain substantial. Evidence for inflammatory activation as an important pathway in disease progression in chronic heart failure has emerged in the last two decades. However, clinical trials of ‘anti‐inflammatory’ therapies (such as anti‐tumor necrosis factor‐α approaches) have to date failed to show benefit in heart failure patients. The Heart Failure Association of the European Society of Cardiology recently organized an expert workshop to address the issue of inflammation in heart failure from a basic science, translational and clinical perspective, and to assess whether specific inflammatory pathways may yet serve as novel therapeutic targets for this condition. This consensus document represents the outcome of the workshop and defines key research questions that still need to be addressed as well as considering the requirements for future clinical trials in this area.Keywords
This publication has 143 references indexed in Scilit:
- Post-infarct remodelling: contribution of wound healing and inflammationCardiovascular Research, 2008
- Acute viral myocarditisEuropean Heart Journal, 2008
- Role of gp130‐mediated signalling pathways in the heart and its impact on potential therapeutic aspectsBritish Journal of Pharmacology, 2008
- Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial InfarctionCirculation, 2008
- Periostin is essential for cardiac healingafter acute myocardial infarctionThe Journal of Experimental Medicine, 2008
- The MBL2 ‘LYQA Secretor’ Haplotype Is an Independent Predictor of Postoperative Myocardial Infarction in Whites Undergoing Coronary Artery Bypass Graft SurgeryCirculation, 2007
- Oxidative stress and redox signalling in cardiac hypertrophy and heart failureHeart, 2007
- Phosphoinositide 3-kinase γ/δ inhibition limits infarct size after myocardial ischemia/reperfusion injuryProceedings of the National Academy of Sciences of the United States of America, 2006
- NADPH Oxidases in Cardiovascular Health and DiseaseAntioxidants and Redox Signaling, 2006
- Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behaviorThe Journal of cell biology, 2002